Evidence map›Paper›PMID 32176612›Full record

ArticleHealthcare policy = Politiques de sante2020

Comparing Childhood Cancer Care Costs in Two Canadian Provinces.

Mary L McBride, Claire de Oliveira, Ross Duncan, Karen E Bremner, Ning Liu, Mark L Greenberg, Paul C Nathan, Paul C Rogers, Stuart J Peacock, Murray D Krahn

Abstract readComparative Study
In one paragraph

Article in Healthcare policy = Politiques de sante, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Kicking Off the 2020s with Healthcare Policy.Healthcare policy = Politiques de sante · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mary L McBrideEmerita Scientist, Cancer Control Research, British Columbia Cancer, Vancouver, BC.
Claire de OliveiraIndependent Scientist and Health Economist, Center for Addiction and Mental Health, Toronto, ON.
Ross DuncanGraduate Student, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC.
Karen E BremnerResearch Associate, Toronto General Hospital Research Institute, University Health Network, Toronto, ON.
Ning LiuSenior Research Analyst, Institute for Clinical Evaluative Sciences, Toronto, ON.
Mark L GreenbergChair in Childhood Cancer Control and Professor of Paediatrics and Surgery, Pediatric Oncology Group of Ontario, Toronto, ON.
Paul C NathanStaff Oncologist and Director, Aftercare Program, The Hospital for Sick Children, Toronto, ON.
Paul C RogersClinical Professor, Division of Hematology, Oncology & Bone Marrow Transplant, BC Children's Hospital, Vancouver, BC.
Stuart J PeacockDistinguished Scientist, Leslie Diamond Chair in Cancer Survivorship, Cancer Control Research, British Columbia Cancer, Vancouver, BC.
Murray D KrahnSenior Scientist and Director, THETA Collaborative, Toronto General Hospital Research Institute, University Health Network, Toronto, ON.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer in children presents unique issues for diagnosis, treatment and survivorship care. Phase-specific comparative cost estimates are important for informing healthcare planning.

objectiveThe aim of this paper is to compare direct medical costs of childhood cancer by phase of care in British Columbia (BC) and Ontario (ON).

methodsFor cancer patients diagnosed at <15 years of age and propensity-score-matched non-cancer controls, we applied standard costing methodology using population-based healthcare administrative data to estimate and compare phase-based costs by province.

resultsPhase-specific cancer-attributable costs were 2%-39% higher for ON than for BC. Leukemia pre-diagnosis costs and annual lymphoma continuing care costs were >50% higher in ON. Phase-specific in-patient hospital costs (the major cost category) represented 63%-82% of ON costs, versus 43%-73% of BC costs. Phase-specific diagnostic tests and procedures accounted for 1.0%-3.4% of ON costs and 2.8%-13.0% of BC costs.

conclusionThere are substantial cost differences between these two Canadian provinces, BC and ON, possibly identifying opportunities for healthcare planning improvement.

Indexed as

Health Care CostsAdolescentBritish ColumbiaChildChild, PreschoolDatabases, FactualHumansNeoplasmsOntario

Identifiers

PMID32176612
PMCPMC7075448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.